From The Washington Post: The experience of a 23 year old diagnosed with colon cancer who joined a research trial for a new immunotherapy drug that, for the first time, attacks a genetic feature in a tumor rather than the disease’s location in the body.
www.washingtonpost.com/national/health-science/this-is-not-the-end-experimental-therapy-that-targets-genes-gives-cancer-patients-hope/2017/05/28/cdce31de-365c-11e7-b373-418f6849a004_story.html
0 Comments
Leave a Reply. |
AuthorCourse instructors, Beth and Rachel will share interesting articles about genetics, genomics and precision medicine that are in the news. Feel free to email them if you've come across an interesting article you'd like to share with other learners! Archives
August 2017
Categories |